Back
CRISPR Therapeutics AG Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
27
CRSP
CRISPR Therapeutics AG
Last Price:
$37.78
Seasonality Move:
21.79%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.63 | Buy |
| 20-day SMA: | 36.55 | Buy |
| 50-day SMA: | 40.9 | Sell |
| 200-day SMA: | 46.21 | Sell |
| 8-day EMA: | 36.89 | Buy |
| 20-day EMA: | 32.04 | Buy |
| 50-day EMA: | 20.78 | Buy |
| 200-day EMA: | 6.95 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.36 | Buy |
| Relative Strength Index (14 RSI): | 49.46 | Sell |
| Chaikin Money Flow: | 99115 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.98 - 41.22) | Buy |
| Bollinger Bands (100): | (37.58 - 47.38) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 37.77 while CRSP 8-day simple moving average is 36.63, which is a Buy signal.
-
The stock price of CRSP is 37.77 while CRISPR Therapeutics AG 20-day SMA is 36.55, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 40.90 while CRSP share price is 37.77, making it a Sell technically.
-
CRSP stock price is 37.77 and CRISPR Therapeutics AG 200-day simple moving average is 46.21, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $37.77. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.2B
Price in USD:
37.77
Share Volume:
1M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
67.88
52-Week Low:
30.04
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 37.77 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 37.77 while CRSP 8-day exponential moving average is 36.89, which is a Buy signal.
-
The stock price of CRSP is 37.77 while CRISPR Therapeutics AG 20-day EMA is 32.04, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 20.78 while CRSP share price is 37.77, making it a Buy technically.
-
CRSP stock price is 37.77 and CRISPR Therapeutics AG 200-day simple moving average is 6.95, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.91 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 6.36, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 49.46, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (33.98 - 41.22), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (37.58 - 47.38), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.